MCK 📈 McKesson - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031
MCK: Pharmaceuticals, Medical Supplies, Technology Solutions, Logistics Services
Mckesson Corporation is a multinational healthcare company that provides a wide range of services and products to the healthcare industry in the United States and internationally. The company operates through four distinct segments, each catering to different aspects of the healthcare ecosystem. The U.S. Pharmaceutical segment is a key player in the distribution of pharmaceutical drugs, including branded, generic, specialty, biosimilar, and over-the-counter medications, as well as other healthcare-related products. This segment also offers an array of services to community-based oncology and specialty practices, such as practice management, technology, clinical support, and business solutions, enabling these practices to streamline their operations and improve patient care.
The Prescription Technology Solutions (RxTS) segment is focused on addressing medication challenges by connecting patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. This segment provides innovative solutions to facilitate access to medication, including prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. By working across the healthcare landscape, RxTS helps to ensure that patients receive the medications they need to manage their health effectively. Additionally, this segment serves biopharma and life sciences partners, supporting the development and delivery of new treatments and therapies.
The Medical-Surgical Solutions segment offers a comprehensive range of medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment plays a critical role in ensuring that healthcare providers have access to the medical supplies and equipment they need to deliver high-quality patient care. By providing efficient distribution and logistics services, McKesson helps to reduce costs and improve the overall efficiency of the healthcare system.
The International segment is responsible for providing distribution and services to wholesale, institutional, and retail customers in Europe and Canada. This segment enables McKesson to expand its reach and support the healthcare needs of patients and providers in these regions. With a rich history dating back to 1833, McKesson Corporation has established itself as a trusted and reliable partner in the healthcare industry, with a strong commitment to improving the health and wellbeing of people around the world. The company is headquartered in Irving, Texas, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol MCK, with the ISIN code US58155Q1031, and is classified under the GICS Sub Industry of Health Care Distributors.
Additional Sources for MCK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MCK Stock Overview
Market Cap in USD | 73,199m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC Sub-Industry | Health Care Distributors |
IPO / Inception | 1994-11-15 |
MCK Stock Ratings
Growth 5y | 90.9% |
Fundamental | 49.6% |
Dividend | 60.2% |
Rel. Strength Industry | 605 |
Analysts | 4.35/5 |
Fair Price Momentum | 674.90 USD |
Fair Price DCF | 957.50 USD |
MCK Dividends
Dividend Yield 12m | 0.45% |
Yield on Cost 5y | 1.76% |
Annual Growth 5y | 9.89% |
Payout Consistency | 94.5% |
MCK Growth Ratios
Growth Correlation 3m | 39.5% |
Growth Correlation 12m | 42% |
Growth Correlation 5y | 98.7% |
CAGR 5y | 31.16% |
CAGR/Mean DD 5y | 5.82 |
Sharpe Ratio 12m | 0.71 |
Alpha | 2.73 |
Beta | 0.73 |
Volatility | 21.10% |
Current Volume | 590.2k |
Average Volume 20d | 720.2k |
As of January 14, 2025, the stock is trading at USD 585.08 with a total of 590,187 shares traded.
Over the past week, the price has changed by +0.80%, over one month by +1.53%, over three months by +15.01% and over the past year by +20.33%.
Partly, yes. Based on ValueRay Fundamental Analyses, McKesson (NYSE:MCK) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.59 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCK as of January 2025 is 674.90. This means that MCK is currently undervalued and has a potential upside of +15.35% (Margin of Safety).
McKesson has received a consensus analysts rating of 4.35. Therefor, it is recommend to buy MCK.
- Strong Buy: 10
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, MCK McKesson will be worth about 741.1 in January 2026. The stock is currently trading at 585.08. This means that the stock has a potential upside of +26.67%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 654 | 11.8% |
Analysts Target Price | 486.3 | -16.9% |
ValueRay Target Price | 741.1 | 26.7% |